Joel P. Giblett

Learn More
BACKGROUND Glucagon-like peptide-1 (7-36) amide (GLP-1) protects against stunning and cumulative left ventricular dysfunction in humans. The mechanism remains uncertain but GLP-1 may act by opening mitochondrial K-ATP channels in a similar fashion to ischemic conditioning. We investigated whether blockade of K-ATP channels with glibenclamide abrogated the(More)
What mediates the effects of thrombospondin-1 in pulmonary hypertension? New evidence for a dual-pronged role of CD47 Increased canonical WNT/b-catenin signalling and myxomatous valve disease Letter in response to glucagon-like peptide-1 mediates cardioprotection by remote ischaemic conditioning 13 ORIGINAL ARTICLES Integrative physiology and(More)
  • 1